<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32(5)</volume><submitter>Feo F</submitter><funding>Regione Toscana (Bando Salute 2018, DD15397</funding><pubmed_abstract>&lt;h4>Background and purpose&lt;/h4>Galactocerebrosidase (GALC) deficiency causes Krabbe disease, a severe lysosomal neurodegenerative condition. Emerging evidence suggests that heterozygous GALC variants may contribute to multiple sclerosis, attention-deficit hyperactivity disorder, and synucleinopathies. We aim to investigate the potential association between GALC heterozygous variants and neurodegenerative disorders, expanding on existing literature.&lt;h4>Methods&lt;/h4>We screened 110 adults with symptoms shared by lysosomal storage disorders (LSDs) and common neurodegenerative diseases, such as Parkinson's disease, Lewy body dementia, and ataxias of different etiology.&lt;h4>Results&lt;/h4>We found GALC heterozygosity in this group to be notably enriched, approximately 1 in 28, compared to 1 in 150 i</pubmed_abstract><journal>European journal of neurology</journal><pagination>e70206</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12090362</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>High Prevalence of GALC Gene Variants in Adults With Neurodegenerative Conditions.</pubmed_title><pmcid>PMC12090362</pmcid><pubmed_authors>Caremani L</pubmed_authors><pubmed_authors>Grigioni G</pubmed_authors><pubmed_authors>Ombrone D</pubmed_authors><pubmed_authors>Tramacere L</pubmed_authors><pubmed_authors>Govoni A</pubmed_authors><pubmed_authors>Rinaldi M</pubmed_authors><pubmed_authors>la Marca G</pubmed_authors><pubmed_authors>Morrone A</pubmed_authors><pubmed_authors>Caciotti A</pubmed_authors><pubmed_authors>Marin F</pubmed_authors><pubmed_authors>Ramat S</pubmed_authors><pubmed_authors>Mei D</pubmed_authors><pubmed_authors>Guerrini R</pubmed_authors><pubmed_authors>Paoli A</pubmed_authors><pubmed_authors>Falliano S</pubmed_authors><pubmed_authors>Feo F</pubmed_authors><pubmed_authors>Ferri L</pubmed_authors><pubmed_authors>Procopio E</pubmed_authors></additional><is_claimable>false</is_claimable><name>High Prevalence of GALC Gene Variants in Adults With Neurodegenerative Conditions.</name><description>&lt;h4>Background and purpose&lt;/h4>Galactocerebrosidase (GALC) deficiency causes Krabbe disease, a severe lysosomal neurodegenerative condition. Emerging evidence suggests that heterozygous GALC variants may contribute to multiple sclerosis, attention-deficit hyperactivity disorder, and synucleinopathies. We aim to investigate the potential association between GALC heterozygous variants and neurodegenerative disorders, expanding on existing literature.&lt;h4>Methods&lt;/h4>We screened 110 adults with symptoms shared by lysosomal storage disorders (LSDs) and common neurodegenerative diseases, such as Parkinson's disease, Lewy body dementia, and ataxias of different etiology.&lt;h4>Results&lt;/h4>We found GALC heterozygosity in this group to be notably enriched, approximately 1 in 28, compared to 1 in 150 i</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-06-01T07:53:40.256Z</modification><creation>2026-04-08T10:46:37.653Z</creation></dates><accession>S-EPMC12090362</accession><cross_references><pubmed>40391866</pubmed><doi>10.1111/ene.70206</doi></cross_references></HashMap>